Increased neurogenesis, enhanced long-term potentiation, AD-associated protein reduction (Aβ and tau), as well as improved cognition and spatial memory have been demonstrated with FUS-BBBO in murine models of AD40–44. The gene discussed is MAPT; the disease is Alzheimer disease.